

(ShareCast News) - Vernalis said results of the phase II proof-of-concept study of its fatty acid amide hydrolase inhibitor, which is being investigat...


(ShareCast News) - The FTSE 250 index was by late on Tuesday afternoon giving up some of the gains made late the day before, as commodities-focused st...


** Pharma co Vernalis up c.15 pct at 5-yr high & on track for biggest one-day rise since Aug 2014 ** FDA approves co's first cough/cold medicine Tuzis...